@article{4e6e65466f80415cb2eea597b90e7cb9,
title = "Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma",
keywords = "Pim-2, bone destruction, myeloma, osteoclastogenesis, receptor activator of NF-κB ligand",
author = "Jumpei Teramachi and Masahiro Hiasa and Asuka Oda and Takeshi Harada and Shingen Nakamura and Ryota Amachi and Hirofumi Tenshin and Masami Iwasa and Shiro Fujii and Kumiko Kagawa and Hirokazu Miki and Kiyoe Kurahashi and Sumiko Yoshida and Itsuro Endo and Tatsuji Haneji and Toshio Matsumoto and Masahiro Abe",
note = "Funding Information: This work was supported in part by Grant-in-Aid for Young Scientists (B) to J.T., R.A., S.N., and H.M., Grants-in-aid for Scientific Research (C) to M.A., and a Grant-in-aid for Cancer Research (17-16) to M.A. from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",
year = "2018",
month = feb,
day = "1",
doi = "10.1111/bjh.14388",
language = "English",
volume = "180",
pages = "581--585",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",
}